Oxford Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Oxford Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$28.3M	Buy	261,761 +50,115	+24%	+$5.76M	3.98%	4
2019 Q4	$24.6M	Buy	211,646 +139,831	+195%	+$16.2M	0.68%	13
2019 Q3	$8.22M	Buy	+71,815	New	+$7.14M	0.2%	131
2018 Q1	–	Sell	-22,419	Closed	-$1.77M	–	2078
2017 Q4	$1.77M	Buy	22,419 +2,994	+15%	+$249K	0.04%	640
2017 Q3	$1.77M	Buy	19,425 +4,677	+32%	+$449K	0.03%	677
2017 Q2	$1.67M	Buy	14,748 +236	+2%	+$26.4K	0.03%	690
2017 Q1	$1.45M	Buy	+14,512	New	+$1.55M	0.04%	651

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Oxford Asset Management's CBPO Position: Q1 2020 in Review

Oxford Asset Management increased its China Biologic Products Holdings, Inc. (CBPO) stake by 24% in Q1 2020, buying an estimated $5.76M and bringing the position to 261,761 shares worth $28.3M. The position accounts for 3.98% of the portfolio, ranked #4.

Oxford Asset Management first reported a position in CBPO in Q1 2017 and has held it in 7 quarters since. 84 funds tracked by Wall St. Rank hold CBPO as of Q1 2020.

Oxford Asset Management held 261,761 shares of China Biologic Products Holdings, Inc. worth $28.3M as of Q1 2020.
Oxford Asset Management bought 50,115 China Biologic Products Holdings, Inc. shares in Q1 2020, an estimated $5.76M.
China Biologic Products Holdings, Inc. made up 3.98% of Oxford Asset Management's portfolio in Q1 2020, its #4 holding.
Oxford Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2017 and has held it in 7 quarters since.
84 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.